SU14813
SU14813 is a potent multi-targeted tyrosine kinase inhibitor with antiangiogenic and antitumor properties, exhibiting IC50 values in the low nanomolar range against VEGFR1, VEGFR2, PDGFRβ, and KIT. It has demonstrated efficacy in both in vitro assays and in vivo tumor models, making it a valuable research tool for studying angiogenesis and oncology.
Product Specifications
CAS Number
627908-92-3
Product Name Alternative
Kit, Inhibitor, inhibit, c-Kit, cKit, CD117, Vascular endothelial growth factor receptor, VEGFR, Platelet-derived growth factor receptor, PDGFR, SCFR, SU14813, SU-14813, SU 14813
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.13% (May vary between batches)
Solubility
DMSO:44 mg/mL (99.44 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.52 mM)
Smiles
Cc1[nH]c (\C=C2/C (=O) Nc3ccc (F) cc23) c (C) c1C (=O) NCC (O) CN1CCOCC1
Molecular Formula
C23H27FN4O4
Molecular Weight
442.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
247597-Biotin 100 µL
IL4R (Interleukin 4 Receptor, CD124, IL4RA) (Biotin)
Sign In for Pricing
View Details